A surge in Venezuelan crude imports, following a landmark U.S.-brokered supply deal, is overwhelming Gulf Coast refiners, creating a supply glut and forcing steep price discounts as the market struggles to absorb the sudden influx.
A disappointing earnings report from industry bellwether Gartner triggered a sharp selloff across the IT services and consulting sector on Thursday, dragging down shares of major players and fueling concerns over a broader growth slowdown.
As Israel's conflicts stretch into a third year, a wave of defense technology startups—founded and staffed by reservists with direct combat experience—is attracting record investment and global demand, despite mounting international scrutiny over Gaza.
Pfizer reported stronger-than-expected fourth-quarter earnings, defying analyst predictions even as revenue from its COVID-19 portfolio plummeted. The pharmaceutical giant's non-COVID products showed robust growth, signaling a strategic shift.
The benchmark diesel price, a key component in fuel surcharges, has risen for the third week in a row. However, a significant shift in futures contracts suggests the recent rally may be losing steam, even as analysts debate underlying structural strength in the market.
PayPal's stock plummeted following disappointing Q4 results and the abrupt departure of its short-tenured CEO, Alex Chriss. The fintech giant now faces a pivotal leadership transition as it seeks to reignite growth.
Soaring child care expenses, now consuming an average of 20% of household income, are compelling parents to deplete savings, delay major purchases, and reconsider career paths, with broader implications for the economy.
Chinese electric vehicle maker NIO has achieved a significant milestone by delivering its one-millionth vehicle, reporting a near-doubling of January sales year-over-year. The company is simultaneously accelerating its global footprint with new market entries in Central Asia and Europe, while rolling out major software upgrades to its existing fleet. This multi-front expansion comes as the global EV sector grapples with intensifying competition and shifting regulatory landscapes.
Elon Musk has reaffirmed plans for a SpaceX mission to place a Dogecoin token on the moon, sparking renewed interest in the meme cryptocurrency ahead of the company's anticipated public offering.
Following a historic single-day plunge in gold and silver prices, global demand for physical bullion surges, turning a market correction into a potential inflection point. Analysts dissect whether the sell-off presents a strategic entry opportunity or signals a deeper fragility, especially in light of JPMorgan's ambitious long-term price target.
PayPal's stock tumbled nearly 20% following a disappointing Q4 report, missing revenue and profit targets. The downturn has reignited debate about whether Elon Musk, a PayPal co-founder, might see strategic value in the payments giant for his 'everything app' ambitions with X.
A key procedural vote in the House of Representatives has set the stage for a final vote to fund major government agencies, likely ending a four-day partial shutdown after intense White House lobbying swayed Republican holdouts.
A sharp divergence defined Tuesday's trading session: the Nasdaq fell over 1% despite strong tech earnings, while precious metals staged a dramatic rebound. Investor sentiment was caught between robust corporate results, hawkish Fed signals, and the ongoing partial government shutdown.
In a high-stakes appeal trial, French prosecutors have formally requested a five-year ban on Marine Le Pen holding elected office, a move that could definitively block the far-right leader's path to the 2027 presidential election over EU fund misuse allegations.
Christopher Johnson, 24, has entered a federal guilty plea admitting to leading a violent crime spree, including the 2022 murder of Irah Sok, a photographer and mother, during a home invasion. Prosecutors recommend a 25-year sentence.
Disappointing Q4 results from industry bellwether Gartner triggered a broad market selloff in the IT services and consulting sector, with shares of EXL and TransUnion among the notable decliners as investors reassess growth prospects.
With a blockbuster portfolio and a pipeline brimming with potential, Axsome Therapeutics is proving its five-year market surge may be only the beginning. Analysts point to label expansions and untapped markets as key drivers for the next phase of growth.
The Danish pharmaceutical giant forecasts a significant drop in revenue for the year, citing fierce competition for its weight-loss drugs and U.S. government pricing initiatives. The projected decline steeper than analyst expectations triggered a sharp sell-off in its U.S.-listed shares.
Spire Inc. (SR) reported robust first-quarter earnings, crediting its natural gas utilities' performance during a historic winter storm and reaffirming its growth targets as it advances a major acquisition and portfolio simplification.
New Phase 3 data for Novo Nordisk's CagriSema shows superior blood sugar control and weight loss compared to its own semaglutide in type 2 diabetes patients. However, analysts note the therapy enters a market where Eli Lilly's tirzepatide has already set a high bar for dual-benefit treatments.
